Assessing Bone Density in Men
- 1 October 2000
- journal article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 15 (10) , 1867-1870
- https://doi.org/10.1359/jbmr.2000.15.10.1867
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Risedronate therapy prevents corticosteroid-induced bone loss : A twelve-month, multicenter, randomized, double-blind, placebo-controlled, parallel-group studyArthritis & Rheumatism, 1999
- Hip Fracture Prediction in Elderly Men and Women: Validation in the Rotterdam StudyJournal of Bone and Mineral Research, 1998
- Alendronate for the Prevention and Treatment of Glucocorticoid-Induced OsteoporosisNew England Journal of Medicine, 1998
- Risk Factors for Hip Fracture in White Men: The NHANES I Epidemiologic Follow-up StudyJournal of Bone and Mineral Research, 1998
- Intermittent Etidronate Therapy to Prevent Corticosteroid-Induced OsteoporosisNew England Journal of Medicine, 1997
- Medical Expenditures for the Treatment of Osteoporotic Fractures in the United States in 1995: Report from the National Osteoporosis FoundationJournal of Bone and Mineral Research, 1997
- Age and sex influences on fall characteristics.Annals of the Rheumatic Diseases, 1994
- Gender differences in vertebral sizes in adults: biomechanical implications.Radiology, 1994
- Prediction of osteoporotic fractures by postural instability and bone density.BMJ, 1993
- A Controlled Trial of the Effect of Calcium Supplementation on Bone Density in Postmenopausal WomenNew England Journal of Medicine, 1990